statistiche ricercatore

Nome	#
Antitumor activity of ZD6126, a novel vascular-targeting agent, is enhanced when combined with ZD1839, an epidermal growth factor receptor tyrosine kinase inhibitor, and potentiates the effects of radiation in a human non-small cell lung cancer xenograft model.	43
Angiogenesis: A target for cancer therapy.	40
Zoledronic acid cooperates with a cyclooxygenase-2 inhibitor and gefitinib in inhibiting breast and prostate cancer.	40
Therapeutic integration of signal transduction targeting agents and conventional anti-cancer treatments.	39
Oral administration of a novel taxane, an antisense oligonucleotide targeting protein kinase A, and the epidermal growth factor receptor inhibitor Iressa causes cooperative antitumor and antiangiogenic activity.	34
Key cancer cell signal transduction pathways as therapeutic targets.	31
Peroxiredoxin-2 plays a pivotal role as multimodal cytoprotector in the early phase of pulmonary hypertension	23
Totale	250

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2018/2019	1	0	0	0	0	0	0	0	0	0	0	0	1
2019/2020	30	9	0	6	0	6	0	0	0	0	2	3	4
2020/2021	51	0	4	8	6	6	6	7	0	6	0	8	0
2021/2022	42	0	0	0	2	0	1	0	1	11	0	13	14
2022/2023	39	2	5	0	0	11	2	0	3	8	4	4	0
2023/2024	32	1	2	4	10	3	0	9	3	0	0	0	0
Totale													250